Do omega-3s help against cardiac arrhythmias?
Fish oil supplements have no demonstrable benefit against cardiac arrhythmias. At high doses they actually increase the risk of atrial fibrillation. Focusing on proven lifestyle changes is more effective.
Fish oil supplements have no demonstrable effect against cardiac arrhythmias. A large Cochrane meta-analysis of 30 randomised studies involving nearly 78,000 participants found virtually no difference compared with placebo. Fish oil also had little to no effect on total mortality or the total number of cardiovascular events.
There is even a serious warning: at high doses, omega-3 supplements increase the risk of atrial fibrillation, the most common cardiac arrhythmia. This applies to pure EPA supplements as well as to the EPA+DHA combination. The risk is dose-dependent: the higher the dose, the greater the risk1. Earlier promising results have therefore not been confirmed in better-designed research -- in fact, they have been reversed.
The plant-based omega-3 fatty acid ALA, found for example in flaxseed, presents a slightly different picture. Two studies involving nearly 5,000 participants found a small indication of fewer cardiac arrhythmias. However, the absolute benefit is small: on average, 91 people need to be treated to prevent one case. The evidence is moderate and rests on only two studies, so this is not yet an established fact.
On the topic of sudden cardiac death, the picture is mixed. Two older randomised studies and animal research observed an anti-arrhythmic effect, but later studies did not broadly confirm this2. Older observational data suggest a link between eating fish and lower rates of sudden cardiac death, but this is not a proven causal relationship3. On the basis of current evidence, fish oil supplements cannot be recommended for this purpose either.
If you genuinely want to reduce your risk of atrial fibrillation, focus on proven approaches: keeping blood pressure under control, losing weight, stopping alcohol and getting sleep apnoea treated4. Omega-3 supplements do not appear in that overview as an effective strategy.
Based on a Cochrane meta-analysis of 30 to 86 randomised studies with up to 162,000 participants (PMID 32114706), multiple large randomised studies on atrial fibrillation (PMID 39102482), a systematic review on lifestyle interventions in atrial fibrillation (PMID 34583808), older randomised data on sudden cardiac death (PMID 22051327) and older observational data on fish consumption and sudden cardiac death (PMID 10479465). The certainty of evidence regarding general cardiac arrhythmias and mortality is low to moderate; the increased risk of atrial fibrillation at high doses comes from robust randomised research.